Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino Acid Moisturizing Cream vs Desonide in Atopic Dermatitis
NCT02286700Phase 3Unknown
- Sponsor
- NeoStrata
- Start
- Nov 2014
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) (2 arms), sponsored by NeoStrata. Primary endpoint: Change in skin effects of an amino acid moisturizing cream and desonide cream at 5 weeks. Status: unknown.
02
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02286700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286700.